Health Care Economist, Head of Market Access and Health Economics Europe @ Middle East @TerumoBCT, but tweets are my own opinions, lecturer for @HS_Fresenius
Register soon for the immersive, in-person TransformAF program. Join renowned experts for #pulsedfieldablation live cases on FARAPULSE™, experience hands-on exhibits, and engage with faculty and peers.
Sign up today: https://t.co/Q9P4cdsUch
#Epeeps#Electrophysiology
A cost-consequence analysis comparing [..] cardiac ablation strategies for [...] paroxysmal AF: [...] savings associated with #PulsedFieldAblation (excluding kit costs) were €850 and €1,301 per patient compared to CRYO and RF ablation [..]. https://t.co/ZxA12VYsn2
@OBisazza, CEO of @MedTech Europe, gives his keynote speech at this year's MedTech Forum in Vienna: "The medical device sector is one of the most innovative in Europe". #medtech#MTF2024
Real-world data of PF (pulsed field ablation) for AF (atrial fibrillation) demonstrates high safety & efficacy and decreased procedure time, Prof. Daniel Scherr concludes. #EHRA2024#BSCEMEA
Prof. Blankenberg sharing benefits of catheter ablation vs. conventional medical therapy in terms of the composite end point of death or hospitalization for worsening of heart failure. #DGK#DGK2024
I am #Hiring! Spannende Möglichkeit für einen #HealthEconomics and #MarketAccess (Senior) Specialist in unserem großartigen Rhythm Management-Team in EMEA, der/die für Deutschland, Österreich und die Schweiz (DACH) zuständig ist.🚀 Mehr Details im Link: https://t.co/PIFu2Q5iUd
The evaluation from my students from last semester has just been unveiled. In all categories I reached an excellent score. Honored and Thrilled!📊🎉🎓 Am looking forward to continue lecturing "Pharmacoeconomic Evaluation and Outcomes Research" @HS_Fresenius in Wiesbaden.
#Farapulse Revolution Story: significant shortening of catheter ablation procedure time, reduction of AF recurrence and significant lowering of complication rate, Prof. Neuzil concludes. #EHRA2023#BSCEMEA
Ensuring timely diagnosis and treatment, RPM can improve patients' health at lower costs, preventing complications and hospitalizations.
Read the publication "#RemotePatientMonitoring-now or never" to discover how patients can benefit from RPM: https://t.co/mS3yq7DyWA
#BSCEMEA
Course "#Leading and Managing Globally" by the @Yale School of #Management and the International Institute for Management Development (IMD): successfully completed.😀
HeartLogic™ has shown in clinical trials to reduce hospitalisations for decompensated #HeartFailure by 74% and hospitalisation LoS by 56%. Learn how HeartLogic™ could help reduce resource utilisation, waste per patient and greenhouse gas emissions.
https://t.co/jP4zZYMzVd
Thanks for a great event last week at @FOMHochschule to the guest lecturers from @BAHNBKK. Your presentations regarding for example #prevention and innovative (#reimbursement) pathways were very well received. Amazing to get together again like this face to face! #FOMHochschule
The future is now: personalized solutions in #electrophysiology. Dr. Kars Neven with the first clinical findings of the PFA technology. Exciting times lie ahead of us! #DGKJahrestagung#Farapulse